AngioDynamics Azione

AngioDynamics FCF/Debito

Rapporto Flusso di Cassa Libero / Debiti di AngioDynamics (ANGO) al 13 ago 2026.

FCF/Debito

0,00

Ultimo aggiornamento:

Rapporto Flusso di Cassa Libero / Debiti di AngioDynamics ammonta a 2026 0,00 . Rapporto Flusso di Cassa Libero / Debiti di AngioDynamics ammontava a 2025 -235,35 % . Diminuisce del % superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

AngioDynamics Analisi delle Azioni

Cosa fa AngioDynamics? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su AngioDynamics azioni

Su Eulerpool è possibile consultare lo sviluppo storico completo del AngioDynamics di Rapporto Flusso di Cassa Libero / Debiti dal 2006, con valori annuali, grafici e analisi dettagliate.

FCL/Debiti misura la percentuale del debito totale che potrebbe essere ripagata dal flusso di cassa libero. È una misura più rigorosa rispetto a FCO/Debiti in quanto tiene conto delle spese in conto capitale.

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare AngioDynamics di Rapporto Flusso di Cassa Libero / Debiti con i competitor del settore e la media industriale per valutare se è attraente.

Access this data via the Eulerpool API

Leva finanziaria — AngioDynamics

Tutte le Metriche Finanziarie — AngioDynamics